IN THE FOUR YEARS siniee Hollander
and Wilkins' demonstrated the antihypertensive properties of chlorothiazide, this drug and numerous sulfonamyl analogues have filled an important place in the management of arterial hypertension. A number of additional related compounds are undergoing clinical trial. Most, if not all, of these compounds produce a salutary diuresis in edematous states and a significant reduction of blood pressure in the majority of hypertensive subjects. However, they do not effect a cure, are prone to side effects and, so far, their use has thrown little light on the underlying mechanisms of hypertension. Opinion differs as to the meanis whereby sulfonamyl congeners lower blood pressure in the hypertensive subject. MIost investigators2-5 agree that the loss of electrolytes and water is responsible for the antihypertensive properties of these drugs, whereas others6 7 suggest that they have additional effects on the systemic blood vessels and tissues.
A search similar to that of the early 1940 's, when investigators were looking for an ideal antihistaminic, is now in progress for an ideal sulfonamyl antihypertensive drug. Such a drug, within limits imposed by the chemical series under consideration, should exhibit mninimal side effects, long duration of action., and no tendency to toleranee. This report is a comparative evaluation of the antihypertensive properties of chlorthalidone, a phthalimidine derivative. and the benzothiazide compounds, chlorothiazidet and hydrochlorothiazide.t Chlorthalidone was administered to a group of ambulatory outpatients who had previouslv been observed over long periods on placebos and benzothiazide compounds. The drugs were given with and without reserpine and a statistical analysis for significance of blood pressure changes was performed.
Chlorthalidone is identified chemically as 3-hydroxy -3 -(4 -chloro -3 -sulfamylphenyl) phthalimidine. As shown in figure 1 , it differs in structure from benizothiadiazine diuretics such as chlorothiazide anid hydrochlorothiazide.
Several reports have confirmed the diuretic effect of chlorthalidone and its usefulness in treating edema of diverse origin. 8 To galin an accurate estimate of the severity and stability of the hypertensive disease, blood pressure was mneasured on several occasions in each patient before specific drug therapy was instituted. Systolic and diastolic pressures were both somewhat higher on the average when the patient was first seen than on subsequent occasions. After a 4.5-month placebo-control period, reproducible readings were generally obtained. The last two readings on each patient before beginning specific therapy, designated first and second control readings, were compared to determine the degree of stability that had been achieved. The variation between the two control readings is indicated in figure 2 for systolic pressure and in figure 3 (table 10) . No significant differences could be detected between chlorthalidone and either of the thiazide diuretics when they were used in combination with reserpine under these circumstances.
Other Diuretic-Reserpine Comparisons
The effect of chlorthalidone, employed alone, was compared with that of thiazide hypertelnsive qualities of most of the sulfonamyl congeners are quite similar and that the superiority of one over another has to do with differences in incidence of sid:e effects and ease of administration. Therefore, it may well be that the antihypertensive properties of this series of compounds are limited to the degree indicated by the data described in this paper and those of previous reports.
The blood pressure effect of chlorthalidone was maintained over periods up to 10 months without the appearance of tolerance. The response was not influenced by sex, age, or known duration of hypertension. However, a significantly greater decrease in both systolic and diastolic pressures occurred in subjects with moderate or severe hypertension than those with mild elevations of blood pressure.
The lesser blood pressure lowering effect of this compound in patients with mild hypertension than in those with severe disease is of interest. This difference is consistent with an assumption that the hypotensive action is directed more to a pathologic than a physiologic blood pressure maintaining mechanism.
Earlier experiences in the treatment of hypertension with diuretic sulfonamides ' 
Maynooth
In the perfect state of the mechanismn at the mouth of the aorta, the semilunar valves, immediately after each contraction of the ventricle, are thrown back across the mnouth of the aorta by the pressure of the blood beyond them, and when adequate to their function of closing the mouth of this vessel, they retain in the aorta the blood sent in from the ventricle, thus keeping the aorta and larger vessels distended. These vessels consequerntly preserve nearly the same bulk during their systole and diastole. But when the semilanar valves, from any of the causes enumerated, beconie incapable of closing the mouth of the aorta, then after each contraction of the ventricle, a portion of the blood just sent into the aorta, greater or less, according to the degree of the inadequacy of the valves, returns back into the ventriele. Hence the ascending aorta and arteries arising from it, pouring back a portion of their contained blood, become, after each contraction of the ventricle, flaccid or lessened in their diamneter. While they are in this state, the ventricle again contracts and impels quickly into these vessels a quantity of blood, which suddenly and greatly dilates them.
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